A phase Ib trial of AGEN 2034 in combination with AGEN 1884

Trial Profile

A phase Ib trial of AGEN 2034 in combination with AGEN 1884

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs AGEN 1884 (Primary) ; AGEN 2034 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Mar 2017 New trial record
    • 09 Mar 2017 According to an Agenus Inc. media release, this trial is expected to initiate in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top